NASDAQ:MASS 908 Devices (MASS) Stock Price, News & Analysis → Your Portfolio’s Shield Against Inflation: Gold’s Surge and AI Breakthroughs (From InvestorPlace) (Ad) Free MASS Stock Alerts $6.56 +0.86 (+15.09%) (As of 05/13/2024 ET) Add Compare Share Share Today's Range$5.81▼$6.6850-Day Range$5.56▼$7.5552-Week Range$4.85▼$12.51Volume1.63 million shsAverage Volume200,745 shsMarket Capitalization$226.25 millionP/E RatioN/ADividend YieldN/APrice Target$14.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get 908 Devices alerts: Email Address 908 Devices MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside113.4% Upside$14.00 Price TargetShort InterestBearish5.36% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.17Based on 15 Articles This WeekInsider TradingAcquiring Shares$178,500 Bought Last QuarterProj. Earnings GrowthGrowingFrom ($1.11) to ($0.95) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.12 out of 5 starsMedical Sector1089th out of 2,771 stocksMeasuring & Controlling Devices, Not Elsewhere Classified Industry16th out of 30 stocks 3.5 Analyst's Opinion Consensus Rating908 Devices has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst Coverage908 Devices has only been the subject of 1 research reports in the past 90 days.Read more about 908 Devices' stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted5.36% of the float of 908 Devices has been sold short.Short Interest Ratio / Days to Cover908 Devices has a short interest ratio ("days to cover") of 7.6.Change versus previous monthShort interest in 908 Devices has recently increased by 8.94%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend Yield908 Devices does not currently pay a dividend.Dividend Growth908 Devices does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for MASS. Previous Next 3.4 News and Social Media Coverage News Sentiment908 Devices has a news sentiment score of 1.17. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 15 news articles for 908 Devices this week, compared to 2 articles on an average week.Search Interest3 people have searched for MASS on MarketBeat in the last 30 days. Previous Next 5.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, 908 Devices insiders have bought more of their company's stock than they have sold. Specifically, they have bought $178,500.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders27.80% of the stock of 908 Devices is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions88.06% of the stock of 908 Devices is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about 908 Devices' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for 908 Devices are expected to grow in the coming year, from ($1.11) to ($0.95) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of 908 Devices is -6.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of 908 Devices is -6.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share Ratio908 Devices has a P/B Ratio of 1.28. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about 908 Devices' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyGuard Against the Coming Financial UpheavalAmerica’s Most Shocking Financial Story… Behind closed doors in D.C., there is a dark political and economic plot underway. That’s why if you have any savings in the bank or own any assets you want to protect, you must watch this new documentary before it’s too late.You can stream it for free right here. About 908 Devices Stock (NASDAQ:MASS)908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.Read More MASS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MASS Stock News HeadlinesMay 10, 2024 | insidertrades.com908 Devices Inc. (NASDAQ:MASS) CEO Acquires $58,300.00 in StockMay 8, 2024 | insidertrades.comInsider Buying: 908 Devices Inc. (NASDAQ:MASS) CEO Acquires 10,000 Shares of StockMay 9, 2024 | americanbankingnews.comKevin J. Knopp Acquires 10,000 Shares of 908 Devices Inc. (NASDAQ:MASS) StockMay 4, 2024 | americanbankingnews.com908 Devices Inc. (NASDAQ:MASS) Forecasted to Post Q2 2024 Earnings of ($0.34) Per ShareMay 4, 2024 | americanbankingnews.comQ2 2024 EPS Estimates for 908 Devices Inc. Decreased by Analyst (NASDAQ:MASS)May 1, 2024 | finance.yahoo.com908 Devices Inc. (NASDAQ:MASS) Q1 2024 Earnings Call TranscriptMay 1, 2024 | bizjournals.comFive things: Kendall construction suit, Bay State Banner, Boston Dynamics and the best time to visit Mount Auburn CemeteryMay 1, 2024 | finance.yahoo.com908 Devices Inc (MASS) (Q1 2024) Earnings Call Transcript Highlights: Strategic Acquisitions ...May 1, 2024 | finance.yahoo.comQ1 2024 908 Devices Inc. Earnings CallApril 30, 2024 | bizjournals.com908 Devices buys 'chemical ID' company for up to $76.2MApril 30, 2024 | msn.comMASS Stock Earnings: 908 Devices Beats EPS, Beats Revenue for Q1 2024April 30, 2024 | finance.yahoo.com908 Devices Inc (MASS) Q1 2024 Earnings: Narrower Losses and Revenue GrowthApril 30, 2024 | msn.com908 Devices beats top-line and bottom-line estimates; updates FY24 outlookApril 30, 2024 | finance.yahoo.com908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue OutlookApril 30, 2024 | businesswire.com908 Devices Acquires RedWave Technology, Expanding its Forensics Product OfferingApril 29, 2024 | markets.businessinsider.com908 Devices earnings preview: what to expectApril 29, 2024 | msn.com908 Devices Q1 2024 Earnings PreviewApril 23, 2024 | businesswire.com908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024April 19, 2024 | msn.comThis Porsche 908/02 “Flunder” Never FlounderedMarch 28, 2024 | msn.comThe drug users being given phones to rebuild their livesMarch 16, 2024 | finance.yahoo.comMASS Apr 2024 7.500 callMarch 14, 2024 | msn.comChina responds to TikTok ban: 'This will inevitably backfire on the U.S.'March 12, 2024 | businesswire.com908 Devices Trace Chemical Identification Technology Adopted by European AgenciesMarch 7, 2024 | markets.businessinsider.comBuy Rating Affirmed for 908 Devices Amidst PAT Growth and Solid Financial OutlookMarch 7, 2024 | insidermonkey.com908 Devices Inc. (NASDAQ:MASS) Q4 2023 Earnings Call TranscriptSee More Headlines Receive MASS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 908 Devices and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/30/2024Today5/13/2024Next Earnings (Estimated)8/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Measuring & controlling devices, not elsewhere classified Sub-IndustryN/A Current SymbolNASDAQ:MASS CUSIPN/A CIK1555279 Webwww.908devices.com Phone857-254-1500FaxN/AEmployees230Year FoundedN/APrice Target and Rating Average Stock Price Target$14.00 High Stock Price Target$14.00 Low Stock Price Target$14.00 Potential Upside/Downside+113.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-36,400,000.00 Net Margins-68.57% Pretax Margin-69.12% Return on Equity-20.87% Return on Assets-17.13% Debt Debt-to-Equity RatioN/A Current Ratio8.37 Quick Ratio7.53 Sales & Book Value Annual Sales$50.23 million Price / Sales4.50 Cash FlowN/A Price / Cash FlowN/A Book Value$5.11 per share Price / Book1.28Miscellaneous Outstanding Shares34,490,000Free Float24,898,000Market Cap$226.25 million OptionableOptionable Beta1.02 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesDr. Kevin J. Knopp Ph.D. (Age 51)Co-Founder, CEO, President & Director Comp: $788.88kDr. Christopher David Brown Ph.D. (Age 49)Co-Founder, Chief Product Officer & Co-Chair of Scientific Advisory Board Comp: $459.7kMr. Joseph H. Griffith IV (Age 49)CFO & Treasurer Comp: $468.98kMr. Steve AraizaCo-FounderMr. Andrew BartfayCo-Founder & Director of Hardware DevelopmentMr. Michael JobinCo-Founder & Director of Product DevelopmentDr. Scott Miller Ph.D.Co-founder & Director of MS EngineeringMr. Michael S. Turner Esq. (Age 57)J.D., Chief Legal & Administrative Officer and Secretary Comp: $97.84kMr. Don Osmer (Age 58)Vice President of Human Resources More ExecutivesKey CompetitorsAlimera SciencesNASDAQ:ALIMProfound MedicalNASDAQ:PROFOrganigramNASDAQ:OGITelomir PharmaceuticalsNASDAQ:TELOElevation OncologyNASDAQ:ELEVView All CompetitorsInsiders & InstitutionsKevin J KnoppBought 10,000 shares on 5/13/2024Total: $64,200.00 ($6.42/share)Vanguard Group Inc.Bought 6,772 shares on 5/10/2024Ownership: 5.310%Kevin J KnoppBought 10,000 shares on 5/9/2024Total: $58,300.00 ($5.83/share)State Board of Administration of Florida Retirement SystemBought 10,548 shares on 5/9/2024Ownership: 0.032%Kevin J KnoppBought 10,000 shares on 5/7/2024Total: $56,000.00 ($5.60/share)View All Insider TransactionsView All Institutional Transactions MASS Stock Analysis - Frequently Asked Questions Should I buy or sell 908 Devices stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for 908 Devices in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" MASS shares. View MASS analyst ratings or view top-rated stocks. What is 908 Devices' stock price target for 2024? 1 Wall Street research analysts have issued 12-month price objectives for 908 Devices' shares. Their MASS share price targets range from $14.00 to $14.00. On average, they expect the company's stock price to reach $14.00 in the next year. This suggests a possible upside of 113.4% from the stock's current price. View analysts price targets for MASS or view top-rated stocks among Wall Street analysts. How have MASS shares performed in 2024? 908 Devices' stock was trading at $11.22 at the beginning of 2024. Since then, MASS stock has decreased by 41.5% and is now trading at $6.56. View the best growth stocks for 2024 here. When is 908 Devices' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 13th 2024. View our MASS earnings forecast. How were 908 Devices' earnings last quarter? 908 Devices Inc. (NASDAQ:MASS) issued its quarterly earnings data on Tuesday, April, 30th. The company reported ($0.33) earnings per share for the quarter, beating the consensus estimate of ($0.36) by $0.03. The business had revenue of $9.99 million for the quarter, compared to analysts' expectations of $9.29 million. 908 Devices had a negative net margin of 68.57% and a negative trailing twelve-month return on equity of 20.87%. The firm's quarterly revenue was up 5.3% on a year-over-year basis. During the same period in the previous year, the company posted ($0.39) earnings per share. What ETFs hold 908 Devices' stock? ETFs with the largest weight of 908 Devices (NASDAQ:MASS) stock in their portfolio include Alger 35 ETF (ATFV).ARK Genomic Revolution ETF (ARKG). What guidance has 908 Devices issued on next quarter's earnings? 908 Devices updated its FY 2024 earnings guidance on Tuesday, April, 30th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $63.0 million-$65.0 million, compared to the consensus revenue estimate of $52.9 million. When did 908 Devices IPO? 908 Devices (MASS) raised $101 million in an IPO on Friday, December 18th 2020. The company issued 6,300,000 shares at a price of $15.00-$17.00 per share. Cowen, SVB Leerink, Stifel and William Blair served as the underwriters for the IPO. Who are 908 Devices' major shareholders? 908 Devices' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (5.31%), Nikko Asset Management Americas Inc. (1.70%), Sumitomo Mitsui Trust Holdings Inc. (1.71%) and State Board of Administration of Florida Retirement System (0.03%). Insiders that own company stock include Christopher D Brown, Christopher D Brown, John Kenneweg, Joseph H Iv Griffith, Kevin J Knopp, Mark Spoto, Michael S Turner, Nicolas Barthelemy, Trent A Basarsky and Trent A Basarsky. View institutional ownership trends. How do I buy shares of 908 Devices? Shares of MASS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:MASS) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersElon’s New Device is About to Shock the WorldInvestorPlaceTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityThe only AI company you should be looking atBehind the MarketsNo experience to confident trader, meet my student…Wealth Builders InstituteCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOIC Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 908 Devices Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
